Gespeichert in:
| Titel: | Environmental Factors in the Pathogenesis of Cardiovascular Diseases |
|---|---|
| Von: |
edited by Dragan M. Djuric, Devendra K. Agrawal.
|
| Person: |
Djuric, Dragan M.
Agrawal, Devendra K. editor. |
| Körperschaft: | |
| Weitere beteiligte Personen: | , |
| Format: | Elektronisch E-Book |
| Sprache: | Englisch |
| Veröffentlicht: |
Cham :
Springer Nature Switzerland : Imprint: Springer,
2024.
|
| Ausgabe: | 1st ed. 2024. |
| Schriftenreihe: | Advances in Biochemistry in Health and Disease,
30 |
| Schlagwörter: | |
| Medienzugang: | https://doi.org/10.1007/978-3-031-62806-1 |
| Zusammenfassung: | Environmental conditions and processes are one of the major pillars on which the human well-being rests. It is the core responsibility of the society to preserve and enhance better conditions for the human well-being. Indeed, there are several evolving unmet needs in public health. Emerging and re-emerging infectious diseases and a surge in the incidence of non-communicable diseases, including cardiovascular diseases (CAD), chronic respiratory diseases, and metabolic diseases have been impediments to sustainable well-being. Many factors are critical in the global surge in the rate and incidence of cardiovascular diseases. These include the shift from acute to chronic conditions, the shift from single risk factor vs. multiple influences, aging population, global health disparities, exposure to lower harmful influences over a longer period, etc. However, the epigenetic factors due to unhealthy environment play a most significant role in the underlying pathogenesis of cardiovascular diseases. Unfortunately, this has been ignored for a long time and realized lately to expand and disseminate knowledge to general population, expand research activities to investigate the cellular and molecular mechanisms, and develop better preventive and treatment strategies. The most significant environmental impoverishment in the pathogenesis of cardiovascular diseases include different genetical, chemical, physical, and biological influences, but not limited to, socio-economic status and lack of nutrients, nutritional aspects including habits, diets and additives, inhaled and ingested pollutants, exhaust gas and gasoline products, tobacco smoke, water pollution, alcohol consumption, soil and mineral pollution, solvents, pesticides, microplastics, non-critical usage of drugs, climate change, extreme atmospheric conditions, extremes in noise and temperature, electromagnetic influences, microwaves and radiation, outdoor light pollution, mental stressors, lack of or over exercise, microbiota and microbiological agents like SARS CoV-2 virus, etc. |
| Umfang: | 1 Online-Ressource (XVIII, 720 p. 46 illus., 39 illus. in color.) |
| ISBN: | 9783031628061 |
| ISSN: | 2512-2150 ; |
Internformat
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | ZDB-2-SBL-978-3-031-62806-1 | ||
| 003 | DE-He213 | ||
| 005 | 20240801130631.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 240801s2024 sz | o |||| 0|eng d | ||
| 020 | |a 9783031628061 |9 978-3-031-62806-1 | ||
| 024 | 7 | |a 10.1007/978-3-031-62806-1 |2 doi | |
| 050 | 4 | |a QP101-110 | |
| 072 | 7 | |a PSA |2 bicssc | |
| 072 | 7 | |a SCI056000 |2 bisacsh | |
| 072 | 7 | |a PSA |2 thema | |
| 082 | 7 | |a 573.1 |2 23 | |
| 245 | 1 | 0 | |a Environmental Factors in the Pathogenesis of Cardiovascular Diseases |h [electronic resource] / |c edited by Dragan M. Djuric, Devendra K. Agrawal. |
| 250 | |a 1st ed. 2024. | ||
| 264 | 1 | |a Cham : |b Springer Nature Switzerland : |b Imprint: Springer, |c 2024. | |
| 300 | |a 1 Online-Ressource (XVIII, 720 p. 46 illus., 39 illus. in color.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Advances in Biochemistry in Health and Disease, |x 2512-2150 ; |v 30 | |
| 505 | 0 | |a Part 1. Introduction -- 1. Introduction Dragan M. Djuric and Devendra K. Agrawal (Serbia, US) -- 2. Human envirome and cardiovascular diseases Professor Kristina Gopcevic and Team (Serbia) -- Part2. Environmental Aspects in the Pathogenesis of Cardiovascular Diseases -- 3. Endocrine disruptors and cardiovascular diseases: a thinly veiled threat Professor Danina M. Muntean and Team (Romania) -- 4. Cardiovascular disease risk factors, immune checkpoints and Tregs Professor Xiaofeng Yang and Team (US) -- 5. Toxic effects of intracellular free zinc ion in cardiomyocytes via zinc-transporters: Structural and functional changes in mitochondria Professor Belma Turan and Team (Turkey) -- 6. Cardiovascular effects of acetylcholinesterase inhibitors Professor Milos Stojiljkovic and Team (Bosnia and Herzegovina) -- 7. Cardiotoxic effects of catecholamines Professor Milos Stojiljkovic and Team (Bosnia and Herzegovina) -- 8. Pathophysiological mechanisms of COVID infection in diabetes Professor Dinender K. Singla and Team (US) -- 9. Magnetic fields and cardiovascular health Professor Nina Japundzic Zigon and Team (Serbia) -- 10. Seasonality of cardiovascular diseases: Roles of natural and anthropogenic factors Professor Leonid P. Churilov and Team (Russia) -- 11. Environmental factors and CABG grafts: histophysiology and strategies for grafts patency rate improvement Professor Milica Labudovic Borovic and Team (Serbia) -- 12. Is homocysteine biomarker of epigenetic-DNA methylation and environmental health risk: Roles in cardiovascular pathophysiology and link with homocysteine-related vitamins? Professor Dragan M. Djuric and Team (Serbia) -- 13. Mental stressors and cardiovascular diseases Professor Antoinette Oliveira Blackman (Brazil) -- 14. Air pollution and the pathogenesis of CVD -to be determined -- 15. Water pollution and the pathogenesis of CVD -to be determined -- Part 3. Genetics and Nutritional Effects in the Pathogenesis of Cardiovascular Diseases -- 16. Interaction between Genetic Factors and Environmental Factors in the Pathogenesis of CVD Professor Devendra K. Agrawal and Team (US) -- 17. Nutrition, Gut Microbiota, and the Pathogenesis of Cardiovascular Diseases to be determined -- Part 4. Prevention of Environmental Factors-induced Cardiovascular Diseases -- 18. Recent trends and advancements in the pathogenesis and prevention of cardiovascular diseases: With special focus on the mitigation of oxidative stress, atherosclerosis, and gut microbiota-induced trimethylamine Professor Harpal Buttar and Team (Hungary) -- 19. The role of exercise in the CVD prevention Professor Dr. Maciej Banach (Poland) -- 20. Cardiovascular adaptation to exercise: from basic science to applied investigations Professor Vladimir Jakovljevic and Team (Serbia) -- 21. French paradox: a role for Akt activation Professor Ferenc Gallyas Jr, and Team (Hungary) -- Part 5. Treatment of Environmental Factors-induced Cardiovascular Diseases -- 22. Potential new drug targets modulating the environmentally induced oxidative stress in the cardiovascular system Professor Zoran Todorovic and Team (Serbia) -- 23. Critical Therapeutic Targets of Human Cardiac Infarction Pathology - Methods to Aid the Adult Hypoxic Heart Professor Ildiko Bock-Marquette and Team (Hungary) -- 24. Angiotensin Converting Enzyme-2 (ACE-2): A target for Novel Drug Development Professor Ramesh K. Goyal and Team (India) -- 25. The role of pharmacogenomics in drug-induced cardiovascular toxicity Professor Ranko Skrbic (Bosnia and Herzegovina) -- 26. Anti-inflammatory therapy and pleiotropic effects of drugs Professor Devendra K. Agrawal and Team (US). | |
| 520 | |a Environmental conditions and processes are one of the major pillars on which the human well-being rests. It is the core responsibility of the society to preserve and enhance better conditions for the human well-being. Indeed, there are several evolving unmet needs in public health. Emerging and re-emerging infectious diseases and a surge in the incidence of non-communicable diseases, including cardiovascular diseases (CAD), chronic respiratory diseases, and metabolic diseases have been impediments to sustainable well-being. Many factors are critical in the global surge in the rate and incidence of cardiovascular diseases. These include the shift from acute to chronic conditions, the shift from single risk factor vs. multiple influences, aging population, global health disparities, exposure to lower harmful influences over a longer period, etc. However, the epigenetic factors due to unhealthy environment play a most significant role in the underlying pathogenesis of cardiovascular diseases. Unfortunately, this has been ignored for a long time and realized lately to expand and disseminate knowledge to general population, expand research activities to investigate the cellular and molecular mechanisms, and develop better preventive and treatment strategies. The most significant environmental impoverishment in the pathogenesis of cardiovascular diseases include different genetical, chemical, physical, and biological influences, but not limited to, socio-economic status and lack of nutrients, nutritional aspects including habits, diets and additives, inhaled and ingested pollutants, exhaust gas and gasoline products, tobacco smoke, water pollution, alcohol consumption, soil and mineral pollution, solvents, pesticides, microplastics, non-critical usage of drugs, climate change, extreme atmospheric conditions, extremes in noise and temperature, electromagnetic influences, microwaves and radiation, outdoor light pollution, mental stressors, lack of or over exercise, microbiota and microbiological agents like SARS CoV-2 virus, etc. | ||
| 650 | 0 | |a Cardiovascular system. | |
| 650 | 0 | |a Physiology. | |
| 650 | 0 | |a Cardiology. | |
| 650 | 0 | |a Epigenetics. | |
| 650 | 0 | |a Mental health. | |
| 650 | 0 | |a Inflammation. | |
| 650 | 0 | |a Pharmacology. | |
| 650 | 1 | 4 | |a Cardiovascular Physiology. |
| 650 | 2 | 4 | |a Cardiology. |
| 650 | 2 | 4 | |a Epigenetics. |
| 650 | 2 | 4 | |a Mental Health. |
| 650 | 2 | 4 | |a Inflammation. |
| 650 | 2 | 4 | |a Pharmacology. |
| 700 | 1 | |a Djuric, Dragan M. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Agrawal, Devendra K. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783031628054 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031628078 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031628085 |
| 830 | 0 | |a Advances in Biochemistry in Health and Disease, |x 2512-2150 ; |v 30 | |
| 966 | 4 | 0 | |l DE-355 |p ZDB-2-SBL |q UBG_PDA_SBL |u https://doi.org/10.1007/978-3-031-62806-1 |3 Volltext |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||
| 912 | |a ZDB-2-SBL | ||
| 049 | |a DE-355 | ||
Datensatz im Suchindex
| DE-BY-UBR_katkey | ZDB-2-SBL-978-3-031-62806-1 |
|---|---|
| _version_ | 1835726566411206656 |
| adam_text | |
| any_adam_object | |
| author2 | Djuric, Dragan M. Agrawal, Devendra K. |
| author2_role | edt edt |
| author2_variant | d m d dm dmd d k a dk dka |
| author_corporate | SpringerLink (Online service) |
| author_corporate_role | |
| author_facet | Djuric, Dragan M. Agrawal, Devendra K. SpringerLink (Online service) |
| building | Verbundindex |
| bvnumber | localUBR |
| callnumber-first | Q - Science |
| callnumber-label | QP101-110 |
| callnumber-raw | QP101-110 |
| callnumber-search | QP101-110 |
| callnumber-sort | QP 3101 3110 |
| callnumber-subject | QP - Physiology |
| collection | ZDB-2-SBL ZDB-2-SXB |
| contents | Part 1. Introduction -- 1. Introduction Dragan M. Djuric and Devendra K. Agrawal (Serbia, US) -- 2. Human envirome and cardiovascular diseases Professor Kristina Gopcevic and Team (Serbia) -- Part2. Environmental Aspects in the Pathogenesis of Cardiovascular Diseases -- 3. Endocrine disruptors and cardiovascular diseases: a thinly veiled threat Professor Danina M. Muntean and Team (Romania) -- 4. Cardiovascular disease risk factors, immune checkpoints and Tregs Professor Xiaofeng Yang and Team (US) -- 5. Toxic effects of intracellular free zinc ion in cardiomyocytes via zinc-transporters: Structural and functional changes in mitochondria Professor Belma Turan and Team (Turkey) -- 6. Cardiovascular effects of acetylcholinesterase inhibitors Professor Milos Stojiljkovic and Team (Bosnia and Herzegovina) -- 7. Cardiotoxic effects of catecholamines Professor Milos Stojiljkovic and Team (Bosnia and Herzegovina) -- 8. Pathophysiological mechanisms of COVID infection in diabetes Professor Dinender K. Singla and Team (US) -- 9. Magnetic fields and cardiovascular health Professor Nina Japundzic Zigon and Team (Serbia) -- 10. Seasonality of cardiovascular diseases: Roles of natural and anthropogenic factors Professor Leonid P. Churilov and Team (Russia) -- 11. Environmental factors and CABG grafts: histophysiology and strategies for grafts patency rate improvement Professor Milica Labudovic Borovic and Team (Serbia) -- 12. Is homocysteine biomarker of epigenetic-DNA methylation and environmental health risk: Roles in cardiovascular pathophysiology and link with homocysteine-related vitamins? Professor Dragan M. Djuric and Team (Serbia) -- 13. Mental stressors and cardiovascular diseases Professor Antoinette Oliveira Blackman (Brazil) -- 14. Air pollution and the pathogenesis of CVD -to be determined -- 15. Water pollution and the pathogenesis of CVD -to be determined -- Part 3. Genetics and Nutritional Effects in the Pathogenesis of Cardiovascular Diseases -- 16. Interaction between Genetic Factors and Environmental Factors in the Pathogenesis of CVD Professor Devendra K. Agrawal and Team (US) -- 17. Nutrition, Gut Microbiota, and the Pathogenesis of Cardiovascular Diseases to be determined -- Part 4. Prevention of Environmental Factors-induced Cardiovascular Diseases -- 18. Recent trends and advancements in the pathogenesis and prevention of cardiovascular diseases: With special focus on the mitigation of oxidative stress, atherosclerosis, and gut microbiota-induced trimethylamine Professor Harpal Buttar and Team (Hungary) -- 19. The role of exercise in the CVD prevention Professor Dr. Maciej Banach (Poland) -- 20. Cardiovascular adaptation to exercise: from basic science to applied investigations Professor Vladimir Jakovljevic and Team (Serbia) -- 21. French paradox: a role for Akt activation Professor Ferenc Gallyas Jr, and Team (Hungary) -- Part 5. Treatment of Environmental Factors-induced Cardiovascular Diseases -- 22. Potential new drug targets modulating the environmentally induced oxidative stress in the cardiovascular system Professor Zoran Todorovic and Team (Serbia) -- 23. Critical Therapeutic Targets of Human Cardiac Infarction Pathology - Methods to Aid the Adult Hypoxic Heart Professor Ildiko Bock-Marquette and Team (Hungary) -- 24. Angiotensin Converting Enzyme-2 (ACE-2): A target for Novel Drug Development Professor Ramesh K. Goyal and Team (India) -- 25. The role of pharmacogenomics in drug-induced cardiovascular toxicity Professor Ranko Skrbic (Bosnia and Herzegovina) -- 26. Anti-inflammatory therapy and pleiotropic effects of drugs Professor Devendra K. Agrawal and Team (US). |
| dewey-full | 573.1 |
| dewey-hundreds | 500 - Natural sciences and mathematics |
| dewey-ones | 573 - Specific physiological systems in animals |
| dewey-raw | 573.1 |
| dewey-search | 573.1 |
| dewey-sort | 3573.1 |
| dewey-tens | 570 - Biology |
| discipline | Biologie |
| edition | 1st ed. 2024. |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>07913nam a22006135i 4500</leader><controlfield tag="001">ZDB-2-SBL-978-3-031-62806-1</controlfield><controlfield tag="003">DE-He213</controlfield><controlfield tag="005">20240801130631.0</controlfield><controlfield tag="007">cr nn 008mamaa</controlfield><controlfield tag="008">240801s2024 sz | o |||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783031628061</subfield><subfield code="9">978-3-031-62806-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-031-62806-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QP101-110</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">PSA</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">SCI056000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">PSA</subfield><subfield code="2">thema</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">573.1</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Environmental Factors in the Pathogenesis of Cardiovascular Diseases</subfield><subfield code="h">[electronic resource] /</subfield><subfield code="c">edited by Dragan M. Djuric, Devendra K. Agrawal.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2024.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham :</subfield><subfield code="b">Springer Nature Switzerland :</subfield><subfield code="b">Imprint: Springer,</subfield><subfield code="c">2024.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XVIII, 720 p. 46 illus., 39 illus. in color.) </subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="b">PDF</subfield><subfield code="2">rda</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Advances in Biochemistry in Health and Disease,</subfield><subfield code="x">2512-2150 ;</subfield><subfield code="v">30</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Part 1. Introduction -- 1. Introduction Dragan M. Djuric and Devendra K. Agrawal (Serbia, US) -- 2. Human envirome and cardiovascular diseases Professor Kristina Gopcevic and Team (Serbia) -- Part2. Environmental Aspects in the Pathogenesis of Cardiovascular Diseases -- 3. Endocrine disruptors and cardiovascular diseases: a thinly veiled threat Professor Danina M. Muntean and Team (Romania) -- 4. Cardiovascular disease risk factors, immune checkpoints and Tregs Professor Xiaofeng Yang and Team (US) -- 5. Toxic effects of intracellular free zinc ion in cardiomyocytes via zinc-transporters: Structural and functional changes in mitochondria Professor Belma Turan and Team (Turkey) -- 6. Cardiovascular effects of acetylcholinesterase inhibitors Professor Milos Stojiljkovic and Team (Bosnia and Herzegovina) -- 7. Cardiotoxic effects of catecholamines Professor Milos Stojiljkovic and Team (Bosnia and Herzegovina) -- 8. Pathophysiological mechanisms of COVID infection in diabetes Professor Dinender K. Singla and Team (US) -- 9. Magnetic fields and cardiovascular health Professor Nina Japundzic Zigon and Team (Serbia) -- 10. Seasonality of cardiovascular diseases: Roles of natural and anthropogenic factors Professor Leonid P. Churilov and Team (Russia) -- 11. Environmental factors and CABG grafts: histophysiology and strategies for grafts patency rate improvement Professor Milica Labudovic Borovic and Team (Serbia) -- 12. Is homocysteine biomarker of epigenetic-DNA methylation and environmental health risk: Roles in cardiovascular pathophysiology and link with homocysteine-related vitamins? Professor Dragan M. Djuric and Team (Serbia) -- 13. Mental stressors and cardiovascular diseases Professor Antoinette Oliveira Blackman (Brazil) -- 14. Air pollution and the pathogenesis of CVD -to be determined -- 15. Water pollution and the pathogenesis of CVD -to be determined -- Part 3. Genetics and Nutritional Effects in the Pathogenesis of Cardiovascular Diseases -- 16. Interaction between Genetic Factors and Environmental Factors in the Pathogenesis of CVD Professor Devendra K. Agrawal and Team (US) -- 17. Nutrition, Gut Microbiota, and the Pathogenesis of Cardiovascular Diseases to be determined -- Part 4. Prevention of Environmental Factors-induced Cardiovascular Diseases -- 18. Recent trends and advancements in the pathogenesis and prevention of cardiovascular diseases: With special focus on the mitigation of oxidative stress, atherosclerosis, and gut microbiota-induced trimethylamine Professor Harpal Buttar and Team (Hungary) -- 19. The role of exercise in the CVD prevention Professor Dr. Maciej Banach (Poland) -- 20. Cardiovascular adaptation to exercise: from basic science to applied investigations Professor Vladimir Jakovljevic and Team (Serbia) -- 21. French paradox: a role for Akt activation Professor Ferenc Gallyas Jr, and Team (Hungary) -- Part 5. Treatment of Environmental Factors-induced Cardiovascular Diseases -- 22. Potential new drug targets modulating the environmentally induced oxidative stress in the cardiovascular system Professor Zoran Todorovic and Team (Serbia) -- 23. Critical Therapeutic Targets of Human Cardiac Infarction Pathology - Methods to Aid the Adult Hypoxic Heart Professor Ildiko Bock-Marquette and Team (Hungary) -- 24. Angiotensin Converting Enzyme-2 (ACE-2): A target for Novel Drug Development Professor Ramesh K. Goyal and Team (India) -- 25. The role of pharmacogenomics in drug-induced cardiovascular toxicity Professor Ranko Skrbic (Bosnia and Herzegovina) -- 26. Anti-inflammatory therapy and pleiotropic effects of drugs Professor Devendra K. Agrawal and Team (US).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Environmental conditions and processes are one of the major pillars on which the human well-being rests. It is the core responsibility of the society to preserve and enhance better conditions for the human well-being. Indeed, there are several evolving unmet needs in public health. Emerging and re-emerging infectious diseases and a surge in the incidence of non-communicable diseases, including cardiovascular diseases (CAD), chronic respiratory diseases, and metabolic diseases have been impediments to sustainable well-being. Many factors are critical in the global surge in the rate and incidence of cardiovascular diseases. These include the shift from acute to chronic conditions, the shift from single risk factor vs. multiple influences, aging population, global health disparities, exposure to lower harmful influences over a longer period, etc. However, the epigenetic factors due to unhealthy environment play a most significant role in the underlying pathogenesis of cardiovascular diseases. Unfortunately, this has been ignored for a long time and realized lately to expand and disseminate knowledge to general population, expand research activities to investigate the cellular and molecular mechanisms, and develop better preventive and treatment strategies. The most significant environmental impoverishment in the pathogenesis of cardiovascular diseases include different genetical, chemical, physical, and biological influences, but not limited to, socio-economic status and lack of nutrients, nutritional aspects including habits, diets and additives, inhaled and ingested pollutants, exhaust gas and gasoline products, tobacco smoke, water pollution, alcohol consumption, soil and mineral pollution, solvents, pesticides, microplastics, non-critical usage of drugs, climate change, extreme atmospheric conditions, extremes in noise and temperature, electromagnetic influences, microwaves and radiation, outdoor light pollution, mental stressors, lack of or over exercise, microbiota and microbiological agents like SARS CoV-2 virus, etc.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cardiovascular system.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Physiology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cardiology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Epigenetics.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Mental health.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Inflammation.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacology.</subfield></datafield><datafield tag="650" ind1="1" ind2="4"><subfield code="a">Cardiovascular Physiology.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Cardiology.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Epigenetics.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Mental Health.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Inflammation.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Pharmacology.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Djuric, Dragan M.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Agrawal, Devendra K.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">SpringerLink (Online service)</subfield></datafield><datafield tag="773" ind1="0" ind2=" "><subfield code="t">Springer Nature eBook</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Printed edition:</subfield><subfield code="z">9783031628054</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Printed edition:</subfield><subfield code="z">9783031628078</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Printed edition:</subfield><subfield code="z">9783031628085</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Advances in Biochemistry in Health and Disease,</subfield><subfield code="x">2512-2150 ;</subfield><subfield code="v">30</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-355</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="q">UBG_PDA_SBL</subfield><subfield code="u">https://doi.org/10.1007/978-3-031-62806-1</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SXB</subfield></datafield><datafield tag="950" ind1=" " ind2=" "><subfield code="a">Biomedical and Life Sciences (SpringerNature-11642)</subfield></datafield><datafield tag="950" ind1=" " ind2=" "><subfield code="a">Biomedical and Life Sciences (R0) (SpringerNature-43708)</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield></record></collection> |
| id | ZDB-2-SBL-978-3-031-62806-1 |
| illustrated | Not Illustrated |
| indexdate | 2025-06-23T13:27:58Z |
| institution | BVB |
| isbn | 9783031628061 |
| issn | 2512-2150 ; |
| language | English |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XVIII, 720 p. 46 illus., 39 illus. in color.) |
| psigel | ZDB-2-SBL UBG_PDA_SBL ZDB-2-SBL ZDB-2-SXB |
| publishDate | 2024 |
| publishDateSearch | 2024 |
| publishDateSort | 2024 |
| publisher | Springer Nature Switzerland : Imprint: Springer, |
| record_format | marc |
| series | Advances in Biochemistry in Health and Disease, |
| series2 | Advances in Biochemistry in Health and Disease, |
| spelling | Environmental Factors in the Pathogenesis of Cardiovascular Diseases [electronic resource] / edited by Dragan M. Djuric, Devendra K. Agrawal. 1st ed. 2024. Cham : Springer Nature Switzerland : Imprint: Springer, 2024. 1 Online-Ressource (XVIII, 720 p. 46 illus., 39 illus. in color.) text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Advances in Biochemistry in Health and Disease, 2512-2150 ; 30 Part 1. Introduction -- 1. Introduction Dragan M. Djuric and Devendra K. Agrawal (Serbia, US) -- 2. Human envirome and cardiovascular diseases Professor Kristina Gopcevic and Team (Serbia) -- Part2. Environmental Aspects in the Pathogenesis of Cardiovascular Diseases -- 3. Endocrine disruptors and cardiovascular diseases: a thinly veiled threat Professor Danina M. Muntean and Team (Romania) -- 4. Cardiovascular disease risk factors, immune checkpoints and Tregs Professor Xiaofeng Yang and Team (US) -- 5. Toxic effects of intracellular free zinc ion in cardiomyocytes via zinc-transporters: Structural and functional changes in mitochondria Professor Belma Turan and Team (Turkey) -- 6. Cardiovascular effects of acetylcholinesterase inhibitors Professor Milos Stojiljkovic and Team (Bosnia and Herzegovina) -- 7. Cardiotoxic effects of catecholamines Professor Milos Stojiljkovic and Team (Bosnia and Herzegovina) -- 8. Pathophysiological mechanisms of COVID infection in diabetes Professor Dinender K. Singla and Team (US) -- 9. Magnetic fields and cardiovascular health Professor Nina Japundzic Zigon and Team (Serbia) -- 10. Seasonality of cardiovascular diseases: Roles of natural and anthropogenic factors Professor Leonid P. Churilov and Team (Russia) -- 11. Environmental factors and CABG grafts: histophysiology and strategies for grafts patency rate improvement Professor Milica Labudovic Borovic and Team (Serbia) -- 12. Is homocysteine biomarker of epigenetic-DNA methylation and environmental health risk: Roles in cardiovascular pathophysiology and link with homocysteine-related vitamins? Professor Dragan M. Djuric and Team (Serbia) -- 13. Mental stressors and cardiovascular diseases Professor Antoinette Oliveira Blackman (Brazil) -- 14. Air pollution and the pathogenesis of CVD -to be determined -- 15. Water pollution and the pathogenesis of CVD -to be determined -- Part 3. Genetics and Nutritional Effects in the Pathogenesis of Cardiovascular Diseases -- 16. Interaction between Genetic Factors and Environmental Factors in the Pathogenesis of CVD Professor Devendra K. Agrawal and Team (US) -- 17. Nutrition, Gut Microbiota, and the Pathogenesis of Cardiovascular Diseases to be determined -- Part 4. Prevention of Environmental Factors-induced Cardiovascular Diseases -- 18. Recent trends and advancements in the pathogenesis and prevention of cardiovascular diseases: With special focus on the mitigation of oxidative stress, atherosclerosis, and gut microbiota-induced trimethylamine Professor Harpal Buttar and Team (Hungary) -- 19. The role of exercise in the CVD prevention Professor Dr. Maciej Banach (Poland) -- 20. Cardiovascular adaptation to exercise: from basic science to applied investigations Professor Vladimir Jakovljevic and Team (Serbia) -- 21. French paradox: a role for Akt activation Professor Ferenc Gallyas Jr, and Team (Hungary) -- Part 5. Treatment of Environmental Factors-induced Cardiovascular Diseases -- 22. Potential new drug targets modulating the environmentally induced oxidative stress in the cardiovascular system Professor Zoran Todorovic and Team (Serbia) -- 23. Critical Therapeutic Targets of Human Cardiac Infarction Pathology - Methods to Aid the Adult Hypoxic Heart Professor Ildiko Bock-Marquette and Team (Hungary) -- 24. Angiotensin Converting Enzyme-2 (ACE-2): A target for Novel Drug Development Professor Ramesh K. Goyal and Team (India) -- 25. The role of pharmacogenomics in drug-induced cardiovascular toxicity Professor Ranko Skrbic (Bosnia and Herzegovina) -- 26. Anti-inflammatory therapy and pleiotropic effects of drugs Professor Devendra K. Agrawal and Team (US). Environmental conditions and processes are one of the major pillars on which the human well-being rests. It is the core responsibility of the society to preserve and enhance better conditions for the human well-being. Indeed, there are several evolving unmet needs in public health. Emerging and re-emerging infectious diseases and a surge in the incidence of non-communicable diseases, including cardiovascular diseases (CAD), chronic respiratory diseases, and metabolic diseases have been impediments to sustainable well-being. Many factors are critical in the global surge in the rate and incidence of cardiovascular diseases. These include the shift from acute to chronic conditions, the shift from single risk factor vs. multiple influences, aging population, global health disparities, exposure to lower harmful influences over a longer period, etc. However, the epigenetic factors due to unhealthy environment play a most significant role in the underlying pathogenesis of cardiovascular diseases. Unfortunately, this has been ignored for a long time and realized lately to expand and disseminate knowledge to general population, expand research activities to investigate the cellular and molecular mechanisms, and develop better preventive and treatment strategies. The most significant environmental impoverishment in the pathogenesis of cardiovascular diseases include different genetical, chemical, physical, and biological influences, but not limited to, socio-economic status and lack of nutrients, nutritional aspects including habits, diets and additives, inhaled and ingested pollutants, exhaust gas and gasoline products, tobacco smoke, water pollution, alcohol consumption, soil and mineral pollution, solvents, pesticides, microplastics, non-critical usage of drugs, climate change, extreme atmospheric conditions, extremes in noise and temperature, electromagnetic influences, microwaves and radiation, outdoor light pollution, mental stressors, lack of or over exercise, microbiota and microbiological agents like SARS CoV-2 virus, etc. Cardiovascular system. Physiology. Cardiology. Epigenetics. Mental health. Inflammation. Pharmacology. Cardiovascular Physiology. Mental Health. Djuric, Dragan M. editor. edt http://id.loc.gov/vocabulary/relators/edt Agrawal, Devendra K. editor. edt http://id.loc.gov/vocabulary/relators/edt SpringerLink (Online service) Springer Nature eBook Printed edition: 9783031628054 Printed edition: 9783031628078 Printed edition: 9783031628085 |
| spellingShingle | Environmental Factors in the Pathogenesis of Cardiovascular Diseases Advances in Biochemistry in Health and Disease, Part 1. Introduction -- 1. Introduction Dragan M. Djuric and Devendra K. Agrawal (Serbia, US) -- 2. Human envirome and cardiovascular diseases Professor Kristina Gopcevic and Team (Serbia) -- Part2. Environmental Aspects in the Pathogenesis of Cardiovascular Diseases -- 3. Endocrine disruptors and cardiovascular diseases: a thinly veiled threat Professor Danina M. Muntean and Team (Romania) -- 4. Cardiovascular disease risk factors, immune checkpoints and Tregs Professor Xiaofeng Yang and Team (US) -- 5. Toxic effects of intracellular free zinc ion in cardiomyocytes via zinc-transporters: Structural and functional changes in mitochondria Professor Belma Turan and Team (Turkey) -- 6. Cardiovascular effects of acetylcholinesterase inhibitors Professor Milos Stojiljkovic and Team (Bosnia and Herzegovina) -- 7. Cardiotoxic effects of catecholamines Professor Milos Stojiljkovic and Team (Bosnia and Herzegovina) -- 8. Pathophysiological mechanisms of COVID infection in diabetes Professor Dinender K. Singla and Team (US) -- 9. Magnetic fields and cardiovascular health Professor Nina Japundzic Zigon and Team (Serbia) -- 10. Seasonality of cardiovascular diseases: Roles of natural and anthropogenic factors Professor Leonid P. Churilov and Team (Russia) -- 11. Environmental factors and CABG grafts: histophysiology and strategies for grafts patency rate improvement Professor Milica Labudovic Borovic and Team (Serbia) -- 12. Is homocysteine biomarker of epigenetic-DNA methylation and environmental health risk: Roles in cardiovascular pathophysiology and link with homocysteine-related vitamins? Professor Dragan M. Djuric and Team (Serbia) -- 13. Mental stressors and cardiovascular diseases Professor Antoinette Oliveira Blackman (Brazil) -- 14. Air pollution and the pathogenesis of CVD -to be determined -- 15. Water pollution and the pathogenesis of CVD -to be determined -- Part 3. Genetics and Nutritional Effects in the Pathogenesis of Cardiovascular Diseases -- 16. Interaction between Genetic Factors and Environmental Factors in the Pathogenesis of CVD Professor Devendra K. Agrawal and Team (US) -- 17. Nutrition, Gut Microbiota, and the Pathogenesis of Cardiovascular Diseases to be determined -- Part 4. Prevention of Environmental Factors-induced Cardiovascular Diseases -- 18. Recent trends and advancements in the pathogenesis and prevention of cardiovascular diseases: With special focus on the mitigation of oxidative stress, atherosclerosis, and gut microbiota-induced trimethylamine Professor Harpal Buttar and Team (Hungary) -- 19. The role of exercise in the CVD prevention Professor Dr. Maciej Banach (Poland) -- 20. Cardiovascular adaptation to exercise: from basic science to applied investigations Professor Vladimir Jakovljevic and Team (Serbia) -- 21. French paradox: a role for Akt activation Professor Ferenc Gallyas Jr, and Team (Hungary) -- Part 5. Treatment of Environmental Factors-induced Cardiovascular Diseases -- 22. Potential new drug targets modulating the environmentally induced oxidative stress in the cardiovascular system Professor Zoran Todorovic and Team (Serbia) -- 23. Critical Therapeutic Targets of Human Cardiac Infarction Pathology - Methods to Aid the Adult Hypoxic Heart Professor Ildiko Bock-Marquette and Team (Hungary) -- 24. Angiotensin Converting Enzyme-2 (ACE-2): A target for Novel Drug Development Professor Ramesh K. Goyal and Team (India) -- 25. The role of pharmacogenomics in drug-induced cardiovascular toxicity Professor Ranko Skrbic (Bosnia and Herzegovina) -- 26. Anti-inflammatory therapy and pleiotropic effects of drugs Professor Devendra K. Agrawal and Team (US). Cardiovascular system. Physiology. Cardiology. Epigenetics. Mental health. Inflammation. Pharmacology. Cardiovascular Physiology. Mental Health. |
| title | Environmental Factors in the Pathogenesis of Cardiovascular Diseases |
| title_auth | Environmental Factors in the Pathogenesis of Cardiovascular Diseases |
| title_exact_search | Environmental Factors in the Pathogenesis of Cardiovascular Diseases |
| title_full | Environmental Factors in the Pathogenesis of Cardiovascular Diseases [electronic resource] / edited by Dragan M. Djuric, Devendra K. Agrawal. |
| title_fullStr | Environmental Factors in the Pathogenesis of Cardiovascular Diseases [electronic resource] / edited by Dragan M. Djuric, Devendra K. Agrawal. |
| title_full_unstemmed | Environmental Factors in the Pathogenesis of Cardiovascular Diseases [electronic resource] / edited by Dragan M. Djuric, Devendra K. Agrawal. |
| title_short | Environmental Factors in the Pathogenesis of Cardiovascular Diseases |
| title_sort | environmental factors in the pathogenesis of cardiovascular diseases |
| topic | Cardiovascular system. Physiology. Cardiology. Epigenetics. Mental health. Inflammation. Pharmacology. Cardiovascular Physiology. Mental Health. |
| topic_facet | Cardiovascular system. Physiology. Cardiology. Epigenetics. Mental health. Inflammation. Pharmacology. Cardiovascular Physiology. Mental Health. |
| work_keys_str_mv | AT djuricdraganm environmentalfactorsinthepathogenesisofcardiovasculardiseases AT agrawaldevendrak environmentalfactorsinthepathogenesisofcardiovasculardiseases AT springerlinkonlineservice environmentalfactorsinthepathogenesisofcardiovasculardiseases |